CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation Post author:Sam Post published:September 26, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Meet the Scientist Who Admits His MS Therapy is 'Largely Ineffective.' November 28, 2017 Gene-Editing Leader Horizon Discovery to Go on Global Hiring Spree April 30, 2017 Vividion Therapeutics Snags $101M from Celgene March 4, 2018